BiotechTube
Public Health Vaccines

Public Health Vaccines

Cambridge, United States· Est.
phvaccines.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40M

Overview

Public Health Vaccines is a preclinical-stage biotech firm dedicated to developing vaccines against emerging infectious diseases, positioning itself as a critical player in pandemic preparedness. The company is privately held and pre-revenue, relying on funding and partnerships to advance its pipeline. With a seasoned leadership team experienced in vaccine development and medical countermeasures, PHV aims to translate scientific expertise into life-saving products for global health security.

Infectious Diseases

Technology Platform

Integrated expertise in vaccine development value chain, leveraging experience from multiple prior vaccine and medical countermeasure programs for rapid response to emerging threats.

Funding History

2
Total raised:$40M
Series A$35M
Seed$5M

Opportunities

The post-COVID-19 landscape has led to unprecedented government and global funding for pandemic preparedness, creating significant opportunities for non-dilutive grants and advanced purchase agreements.
The ongoing emergence of novel pathogens ensures a persistent need for new vaccine platforms and rapid-response capabilities, where a focused, experienced team can provide significant value.

Risk Factors

The company faces high scientific risk due to the inherent challenges of developing effective vaccines against novel pathogens, and substantial funding risk as a pre-revenue entity reliant on competitive grants and investor capital.
Furthermore, the commercial market is largely confined to government stockpiling, which may limit profitability and attract intense competition from larger, resource-rich players.

Competitive Landscape

PHV competes in a crowded field that includes global vaccine giants (e.g., Pfizer, Moderna, GSK), large biotechs with mRNA/platform technologies, and numerous academic and non-profit research consortia. Differentiation relies on proven development experience, speed, and the ability to form strategic partnerships with government and public health organizations.

More companies in United States →